WILLIAM E. ROTE
CIK 1698262 · Chief Research Officer · last filed 2026-05-06
WILLIAM E. ROTE is a Chief Research Officer who has filed 61 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for TVTX, was dated May 6, 2026. Across all open-market trades the lifetime net is −$5.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.77M
2
61
-$5.22M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Chief Research Officer | 118,237 | $65.71 | $7.77M | -$4.65M | 28 | 2026-05-06 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Senior Vice President, R&D | 24,086 | — | — | -$567.0K | 19 | 2020-11-17 |
Recent Filings
61 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | TVTX | Notice (144) | −2,763 | -$121.4K | EDGAR |
| 2026-05-06 | TVTX | Mixed | +1,487 | -$121.4K | EDGAR |
| 2026-04-23 | TVTX | Sell (S) | −9,100 | -$355.7K | EDGAR |
| 2026-04-22 | TVTX | Notice (144) | −9,100 | -$355.7K | EDGAR |
| 2026-04-15 | TVTX | Grant (A) | +14,000 | $0 | EDGAR |
| 2026-02-03 | TVTX | Notice (144) | −12,446 | -$409.1K | EDGAR |
| 2026-02-03 | TVTX | Mixed | +7,644 | -$409.1K | EDGAR |
| 2025-12-29 | TVTX | Notice (144) | −60,000 | -$2.41M | EDGAR |
| 2025-12-29 | TVTX | Mixed | — | -$1.17M | EDGAR |
| 2025-05-05 | TVTX | Notice (144) | −3,198 | -$67.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.